Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
55.66 (1y: +26%)
Market Cap 3.96 B P/E(ttm) 16.00
Enterprise Value 5.82 B P/B 1.50
EGN- NYSE (USA)
Energen Corp
  • Currently 2/5
Business Predictability Rank: 2-Star
Back Testing Results:
Average gain of all 2-Star stocks: 6% per year.
% of Stocks that are in still loss if held for 10yrs: 16%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$55.66
Switch to:
Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,959Revenue $M1,691Net Margin (%)15.7Z-Score1.4
Enterprise Value $M5,804EPS $3.5Operating Margin %28.4F-Score6
P/E(ttm))16.0Cash Flow Per Share $7.9Pre-tax Margin (%)24.6Higher ROA y-yY
Price/Book1.510-y EBITDA Growth Rate %10.6Quick Ratio0.7Cash flow > EarningsY
Price/Sales2.45-y EBITDA Growth Rate %4.3Current Ratio0.4Lower Leverage y-yY
Price/Cash Flow5.7y-y EBITDA Growth Rate %26.8ROA % (ttm)4.1Higher Current Ratio y-yN
Dividend Yield %1.0Insider Buy (3m)0ROE % (ttm)9.5Less Shares Outstanding y-yN
Payout Ratio %16.2Shares Outstanding M72.2ROI % (ttm)6.8Gross Margin Increase y-yY

Gurus Latest Trades with EGN

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Number of guru portfolios checked: 51.
Total Records: 18
TickerGuruDate Action
 Impactdown Price Range
(Average)* 		Current Price Change from Average Comment Current Shares
EGNGeorge Soros 2013-03-31 Add0.43%$44.87 - $52.01
($48.09)		 $ 55.8316%Add 183.51%1,094,846
EGNDaniel Loeb 2013-03-31 Sold Out -0.35%$44.87 - $52.01
($48.09)		 $ 55.8316%Sold Out0
EGNDaniel Loeb 2012-12-31 Buy 0.35%$42.21 - $54.13
($46.75)		 $ 55.8319%New holding, 425000 sh.425,000
EGNMeridian Funds 2012-12-31 Buy 0.27%$42.21 - $54.13
($46.75)		 $ 55.8319%New holding, 154100 sh.154,100
EGNGeorge Soros 2012-12-31 Buy 0.21%$42.21 - $54.13
($46.75)		 $ 55.8319%New holding, 386173 sh.386,173
EGNDavid Dreman 2011-12-31 Add0.16%$38.8 - $51.94
($48.25)		 $ 55.8316%Add 27.62%663,305
EGNRay Dalio 2011-12-31 Sold Out -0.11%$38.8 - $51.94
($48.25)		 $ 55.8316%Sold Out0
EGNJoel Greenblatt 2011-12-31 Sold Out -0.09%$38.8 - $51.94
($48.25)		 $ 55.8316%Sold Out0
EGNDavid Dreman 2011-09-30 Buy 0.53%$40.29 - $62.09
($51.05)		 $ 55.839%New holding, 519732 sh.519,732
EGNRay Dalio 2011-09-30 Buy 0.11%$40.29 - $62.09
($50.82)		 $ 55.8310%New holding, 186300 sh.186,300
EGNJoel Greenblatt 2011-09-30 Add0.03%$40.29 - $62.09
($51.05)		 $ 55.839%Add 52.73%12,858
EGNJoel Greenblatt 2011-03-31 Add0.05%$48.26 - $63.36
($57.73)		 $ 55.83-3%Add 30.31%10,486
EGNMario Gabelli 2011-03-31 Sold Out $48.26 - $63.36
($57.73)		 $ 55.83-3%Sold Out0
EGNGeorge Soros 2011-03-31 Sold Out $48.26 - $63.36
($57.73)		 $ 55.83-3%Sold Out0
EGNJoel Greenblatt 2010-12-31 Buy 0.13%$43.57 - $48.52
($45.84)		 $ 55.8322%New holding, 8047 sh.8,047
EGNGeorge Soros 2010-12-31 Reduce$43.57 - $48.52
($45.84)		 $ 55.8322%Reduce -49.44%4,500
EGNMario Gabelli 2010-12-31 Reduce$43.57 - $48.52
($45.84)		 $ 55.8322%Reduce -20.69%23,000
EGNGeorge Soros 2010-06-30 Buy 0.01%$43.1 - $49.76
($46.7)		 $ 55.8320%New holding, 8500 sh.8,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.
Total Records: 18

EGN is held by these Gurus:

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
EGN George Soros 2013-03-311,094,8461.520.67+183.51%
EGN David Dreman 2013-03-31615,7380.850.85+4.24%
EGN Meridian Funds 2013-03-31154,1000.210.29
EGN Daniel Loeb 2013-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


EGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hayes, John JosephSenior Officer 2013-04-11Buy61,000$0.02278200view
Hayes, John JosephSenior Officer 2013-04-10Buy100,000$0.02278200view
BAN STEPHEN DDirector 2013-03-28Sell1,000$51.857.35view
YOUNGBLOOD GARY Cand Retired Officer 2013-03-21Sell5,000$50.779.63view
BAN STEPHEN DDirector 2012-09-21Sell1,000$53.93.27view
YOUNGBLOOD GARY Cand Retired Officer 2012-07-27Sell6,000$50.1411.01view
REYNOLDS D CPresident of Subsidiary 2011-12-01Sell1,000$51.188.75view
REYNOLDS D CPresident of Subsidiary 2011-11-18Sell300$49.1713.2view
Dewey Kenneth W.Director 2011-08-08Buy8,100$45.3722.68view
BAN STEPHEN DDirector 2011-03-31Sell600$62.66-11.17view

Press Releases about EGN :

Quarterly/Annual Reports about EGN:

News about EGN:

Articles On GuruFocus.com
My 3 Cheap Dividend Champions with Double-Digit Earnings Growth Feb 05 2013 
Energen Corp: Fundamental Stock Research Analysis Dec 18 2012 
Energen Corp: Stock Research Analysis Sep 24 2012 
Natural Gas Prices Tick Up on Hot Weather But Investors Shouldn’t Expect Much More Upside Aug 08 2012 
5 Oil & Gas Stocks To Consider Now Mar 25 2012 
High Yield Stocks Boosting Distributions Jan 30 2012 
28 Dividend Stocks Acting Like a Money Machine Jan 31 2011 
Energen Corp. Reports Operating Results (10-Q) Nov 04 2010 
Energen Corp. Reports Operating Results (10-Q) Aug 03 2010 
Energen Corp. Reports Operating Results (10-Q) May 07 2010 

More From Our Partners
Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Drugs Laggard May 23 2013 - THESTREET

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK